[Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis]. 2007

Yi-fang Ping, and Xiao-hong Yao, and Xiu-wu Bian, and Jian-hong Chen, and Rong Zhang, and Liang Yi, and Zhi-hua Zhou
Institute of Pathology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.

OBJECTIVE To isolate, culture and identify glioma stem cells from human malignant glioma cell line U87, and investigate the changes of pro-angiogenic factors production by glioma stem cells followed by activation of CXCR4 and observe their tumorigenesis as well as the expression of vascular endothelial growth factor when implanted into nude mice. METHODS The ratio of CD133 positive cells was detected by flow cytometry. Magnetic separation of CD133 positive cells was carried out on the magnetic cell sorting system (MACS). Expression of nestin, glial fibrillary acidic protein (GFAP) and CXCR4 on tumorspheres was detected by indirect immunofluorescence under confocal laser scanning microscopy. The functional activation of CXCR4 was assessed by calcium mobilization experiments. ELISA was used to detect the production of vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) in conditioned medium. Glioma stem cells were implanted into nude mice to assess their tumorigenesis ability and the expression of VEGF. RESULTS The ratio of CD133 positive cells with stem cell property was 0.5% in U87 cells. Activation of CXCR4 on glioma stem cells induced calcium mobilization and increased VEGF and IL-8 protein secretion. CD133 positive cells secreted more VEGF and IL-8 than their negative counterparts in vitro. Tumors derived from CD133 positive cells grew more rapidly and expressed elevated level of VEGF than their negative counterparts. CONCLUSIONS There are a small fraction of glioma stem cells in human glioblastoma cell line U87. Expressing functional CXCR4 and secreting more pro-angiogenic factors may be involved in tumor angiogenesis mediated by glioma stem cells.

UI MeSH Term Description Entries
D007381 Intermediate Filament Proteins Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein. Fibroblast Intermediate Filament Proteins,Filament Proteins, Intermediate,Proteins, Intermediate Filament
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D005260 Female Females
D005904 Glial Fibrillary Acidic Protein An intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000. Glial Intermediate Filament Protein,Astroprotein,GFA-Protein,Glial Fibrillary Acid Protein,GFA Protein

Related Publications

Yi-fang Ping, and Xiao-hong Yao, and Xiu-wu Bian, and Jian-hong Chen, and Rong Zhang, and Liang Yi, and Zhi-hua Zhou
November 2016, Neuroscience,
Yi-fang Ping, and Xiao-hong Yao, and Xiu-wu Bian, and Jian-hong Chen, and Rong Zhang, and Liang Yi, and Zhi-hua Zhou
May 2019, Journal of experimental & clinical cancer research : CR,
Yi-fang Ping, and Xiao-hong Yao, and Xiu-wu Bian, and Jian-hong Chen, and Rong Zhang, and Liang Yi, and Zhi-hua Zhou
July 2023, BMC cancer,
Yi-fang Ping, and Xiao-hong Yao, and Xiu-wu Bian, and Jian-hong Chen, and Rong Zhang, and Liang Yi, and Zhi-hua Zhou
March 2024, BMC cancer,
Yi-fang Ping, and Xiao-hong Yao, and Xiu-wu Bian, and Jian-hong Chen, and Rong Zhang, and Liang Yi, and Zhi-hua Zhou
January 2010, Cancer biology & therapy,
Yi-fang Ping, and Xiao-hong Yao, and Xiu-wu Bian, and Jian-hong Chen, and Rong Zhang, and Liang Yi, and Zhi-hua Zhou
May 2015, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Yi-fang Ping, and Xiao-hong Yao, and Xiu-wu Bian, and Jian-hong Chen, and Rong Zhang, and Liang Yi, and Zhi-hua Zhou
May 2012, Histology and histopathology,
Yi-fang Ping, and Xiao-hong Yao, and Xiu-wu Bian, and Jian-hong Chen, and Rong Zhang, and Liang Yi, and Zhi-hua Zhou
December 2014, Cancer research,
Yi-fang Ping, and Xiao-hong Yao, and Xiu-wu Bian, and Jian-hong Chen, and Rong Zhang, and Liang Yi, and Zhi-hua Zhou
November 2011, Cancer research,
Yi-fang Ping, and Xiao-hong Yao, and Xiu-wu Bian, and Jian-hong Chen, and Rong Zhang, and Liang Yi, and Zhi-hua Zhou
February 2011, Journal of molecular and cellular cardiology,
Copied contents to your clipboard!